Abstract
Deficiency of microsomal glucose-6-phosphatase in liver and kidney leads to glycogen storage disease type la (GSD 1a). Notwithstanding intensive dietary therapy, moderate to severe dyslipidaemia and microal-buminuria, both known atherosclerotic risk factors, remain present. Although more patients reach adult age, no information is still available about accelerated athero-sclerosis. the aim of our study was to investigate whether GSD 1a was associated with premature atherosclerosis. In nine adolescent patients (mean age 22.7±3.4 years) and nine matched healthy control subjects, lipid profile, blood pressure, ankle-brachial indices, aortic distensibility and intima-media thickness (IMT) of the carotid and femoral arteries were determined. As expected, lipid profiles were significantly unfavourable in the patient group compared with the control group. No differences were found in blood pressure, ankle-brachial indices and aortic distensibility between both groups. IMT segments were comparable in both groups, with even thinner segments in the patient group. In different multivariate models, GSD la remained an independent predictor for a thinner IMT (R2=0.90; \=−0.69;P=0.018).Conclusion: glycogen storage disease type 1a is not associated with premature atherosclerosis, despite the existence of longstanding dyslipidaemia and microalbuminuria.
Similar content being viewed by others
Abbreviations
- ACE :
-
angiotensin-converting enzyme
- BMI :
-
body mass index
- GSD :
-
glycogen storage disease
- IMT :
-
intima-media thickness
References
Bandsma RHJ, Rake JP, Smit GPA, Princen HMG, Neese RA, Hellerstein MK, Kuipers F (2000) Severe hyperlipidemia due to increased lipid synthesis rates associated with resistance of lipoproteins to oxidative modification in patients with glucose 6-phosphatase deficiency (abstract). Diabetes 49[Suppl 1]: A293
Fernandes J, Leonard JV, Moses SW, Odièvre M, Di Rocco M, Schaub J, Smit GPA, Ullrich K, Durand P (1988) Glycogen storage disease: recommendations for treatment. Eur J Pediatr 147: 226–228
Fernandes J, Alaupovic, P, Wit JM (1989) Gastric drip feeding in patients with glycogen storage disease type I: its effects on growth and plasma lipids and apolipoproteins. Pediatr Res 25: 327–331
Greene HL, Swift LL, Knapp HR (1991) Hyperlipidemia and fatty acid composition in patients treated for type Ia glycogen storage disease. J Pediatr 119: 398–403.
Katz S, Globerman A, Avitzour M, Dolfin T (1997) The anklebrachial index in normal neonates and infants is significantly lower than in older children and adults J Pediatr Surg 32: 269–271
Laogun AA, Gosling RG (1982) In vivo arterial compliance in man. Clin Phys Physiol Meas 3: 201–212
Lee PJ, Celermajer DS, Robinson J, McCarthy SN, Betteridge DJ, Leonard JV (1994) Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type Ia. Atherosclerosis 110: 95–100.
Lehmann ED, Watts GF, Fatemi-Langroudi B, Gosling RG (1992) Aortic compliance in young patients with heterozygous familial hypercholesterolaemia. Clin Sci 83: 717–721.
Lonn EM, Yusuf S, Dzavik V, Doris CI, Yi Q, Smith S, Moore-Cox A, Bosch J, Riley WA, Teo KK (2001) Effects of ramipril and vitamin E on atherosclerosis. The study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 103: 919–925.
MacMahon S, Sharpe N, Gamble G, Clague A, Mhurchu CN, Clark T Hart H, Scott J, White H (2000) Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. Prevention of atherosclerosis with ramipril. J Am Coll Cardiol 36: 438–443
Marti GE, Rick ME, Sidbury, J, Gralnick HR (1986) DDAVP infusion in five patients with type Ia glycogen storage disease and associated correction of prolonged bleeding times. Blood 68: 180–184.
Mason HH, Andersen DH (1955) Glycogen disease of the liver (Von Gierke's disease) with hepatomata. Pediatrics 16: 785–800
Moorhead JF, El-Nahas M, Chan MK, Varghese Z (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2: 1309–1311
Obara K, Saito T, Sato, H, Ogawa M, Igarashi Y, Yoshinaga K (1993) Renal histology in two adult patients with type I glycogen storage disease. Clin Nephrol 39: 59–64
Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340: 115–126
Talente GM, Coleman RA, Alter C, Baker, L, Brown BI, Cannon RA, Chen Y-T, Crigler Jr JF, Ferreira P, Haworth JC, Herman GE, Issenman RM, Keating JP, Linde R, Roe TF, Senior B, Wolfsdorf JI (1994) Glycogen storage disease in adults. Ann Int Med 120: 218–226.
Tonstad S, Joakimsen O, Stensland-Bugge E, Leren TP, Ose L, Russell D, Bønaa, KH (1996) Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects Arterioscler Thromb Vasc Biol 16: 984–991
Author information
Authors and Affiliations
Corresponding author
Additional information
Published online: 2 July 2002
Rights and permissions
About this article
Cite this article
Ubels, F.L., Rake, J.P., Slaets, J.P.J. et al. Is glycogen storage disease 1a associated with atherosclerosis?. Eur J Pediatr 161, S62–S64 (2002). https://doi.org/10.1007/BF02679997
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02679997